Montelukast vs Paritaprevir
Montelukast vs Paritaprevir: Overview
This comparison examines the pharmacological differences between Montelukast and Paritaprevir.
Mechanism of Action
Montelukast: Selective leukotriene D4 receptor antagonist.
Pharmacokinetics
Half-life: Montelukast β 2.7-5.5 hours.
Chemical Properties
Molecular Formula: Montelukast β C35H36ClNO3S.
Molecular Weight: Montelukast β 586.1800 g/mol.
Type: Montelukast β Small molecule; Paritaprevir β Small molecule.